High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus

International Journal of Rheumatic Diseases

Volumn 16, Issue 6, 2013, Pages 709-714

  Tung, Yi Ching ^a   Ke, Liang Yin ^a,b   Tsai, Shih Meng ^a   Lu, Po Liang ^b,c   Tsai, Wen Chan ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Epstein Barr virus (EBV); Human herpesvirus 8 (HHV 8); Systemic lupus erythematosus (SLE)

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SEROPREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; YOUNG ADULT;

EPSTEIN-BARR VIRUS (EBV); HUMAN HERPESVIRUS 8 (HHV-8); SYSTEMIC LUPUS ERYTHEMATOSUS (SLE);

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; TAIWAN; VIRUS LATENCY; YOUNG ADULT;

EID: 84891373709     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12193     Document Type: Article

References (34)

1. Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358, 929-39.
2. Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y (2012) Systemic lupus erythematosus one disease or many? Autoimmun Rev 11, 593-5.
3. Deng Y, Tsao BP (2010) Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 6, 683-92.
4. Elkon KB, Wiedeman A (2012) Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol 24, 499-505.
5. Sestak AL, Furnrohr BG, Harley JB, Merrill JT, Namjou B (2011) The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis 70 (Suppl. 1), i37-43.
6. Draborg AH, Jørgensen JM, Müller H et al. (2012) Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients. Scand J Rheumatol 41, 280-9.
7. James JA, Robertson JM (2012) Lupus and Epstein-Barr. Curr Opin Rheumatol 24, 383-8.
8. Chang Y, Cesarman E, Pessin MS et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 265, 1865-9.
9. Mesri EA, Cesarman E, Arvanitakis L et al. (1996) Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 183, 2385-90.
10. Parravicini C, Chandran B, Corbellino M et al. (2000) Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156, 743-9.
11. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332, 1186-91.
12. Newton R, Carpenter L, Casabonne D et al. (2006) A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. Br J Cancer 94, 1504-9.
13. Nsubuga MM, Biggar RJ, Combs S et al. (2008) Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions. Cancer Lett 263, 182-8.
14. Sun Y, Sun S, Li W, Li B, Li J (2011) Prevalence of human herpesvirus 8 infection in systemic lupus erythematosus. Virol J 8, 210.
15. Ke GM, Cheng HL, Ke LY et al. (2006) Development of a quantitative Light Cycler real-time RT-PCR for detection of avian reovirus. J Virol Methods 133, 6-13.
16. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA (2005) EBV and systemic lupus erythematosus: a new perspective. J Immunol 174, 6599-607.
17. Kang I, Quan T, Nolasco H et al. (2004) Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172, 1287-94.
18. Yu SF, Wu HC, Tsai WC et al. (2005) Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med Microbiol Immunol 194, 115-20.
19. Lu JJ, Chen DY, Hsieh CW, Lan JL, Lin FJ, Lin SH (2007) Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 16, 168-75.
20. Jalilvand S, Shoja Z, Mokhtari-Azad T (2011) Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer 6, 5.
21. Pietrosi G, Vizzini G, Pipitone L et al. (2011) Primary and reactivated HHV8 infection and disease after liver transplantation: a prospective study. Am J Transplant 11, 2715-23.
22. Luppi M, Barozzi P, Schulz TF et al. (2000) Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 343, 1378-85.
23. Luppi M, Barozzi P, Schulz TF et al. (2000) Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood 96, 2355-7.
24. Regamey N, Tamm M, Wernli M et al. (1998) Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 339, 1358-63.
25. Huang JY, Chiang YJ, Lai PC et al. (2004) Posttransplant Kaposi's sarcoma: report from a single center. Transplant Proc 36, 2145-7.
26. Chou AL, Huang WW, Lin MN, Su CC (2010) Human herpesvirus type 8 in patients with cirrhosis independent of thrombocytopenia. J Clin Pathol 63, 254-8.
27. Marcelin AG, Motol J, Guihot A et al. (2007) Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease. J Infect Dis 196, 1163-6.
28. Sergerie Y, Abed Y, Roy J, Boivin G (2004) Comparative evaluation of three serological methods for detection of human herpesvirus 8-specific antibodies in Canadian allogeneic stem cell transplant recipients. J Clin Microbiol 42, 2663-7.
29. Tedeschi R, Bidoli E, Agren A et al. (2006) Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Vasterbotten County, Sweden. J Med Virol 78, 372-8.
30. Hudnall SD, Chen T, Allison P, Tyring SK, Heath A (2008) Herpesvirus prevalence and viral load in healthy blood donors by quantitative real-time polymerase chain reaction. Transfusion 48, 1180-7.
31. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED (2006) Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 10, R60.
32. Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring SK (2002) Kaposi's sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol 47, 641-55.
33. Grzegorzewska AE, Frankiewicz D, Breborowicz D, Matlawska I, Bylka W (2012) Disseminated cutaneous Kaposi sarcoma in a patient receiving triptolide/tripdiolide for rheumatoid arthritis. Med Sci Monit 18, CS67-71.
34. Bret J, Hernandez J, Aquilina C, Zabraniecki L, Fournie B (2009) Kaposi's disease in a patient on adalimumab for rheumatoid arthritis. Joint Bone Spine 76, 721-2.